UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease
Abstract Anaemia is common in chronic kidney disease (CKD) encompassing non-dialysis dependent CKD (NDD-CKD) and dialysis dependent CKD (DD-CKD); people on peritoneal dialysis (PD) and haemodialysis (HD); and kidney transplant recipients (KTR). Iron deficiency and erythropoietin deficiency are the m...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-025-04115-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850156655180775424 |
|---|---|
| author | Sunil Bhandari Sebastian Spencer Ben Oliveira Ashraf Mikhail Owain Brooks Gareth Bryant Michelle Willicombe Richard Baines Louise Alldridge Sally Haslam-England |
| author_facet | Sunil Bhandari Sebastian Spencer Ben Oliveira Ashraf Mikhail Owain Brooks Gareth Bryant Michelle Willicombe Richard Baines Louise Alldridge Sally Haslam-England |
| author_sort | Sunil Bhandari |
| collection | DOAJ |
| description | Abstract Anaemia is common in chronic kidney disease (CKD) encompassing non-dialysis dependent CKD (NDD-CKD) and dialysis dependent CKD (DD-CKD); people on peritoneal dialysis (PD) and haemodialysis (HD); and kidney transplant recipients (KTR). Iron deficiency and erythropoietin deficiency are the most common causes of anaemia in people with CKD, especially those requiring kidney replacement therapy (KRT). The Renal National Service Framework and National Institute for Health and Clinical Excellence in the UK, and Kidney Disease Improving Global Outcomes (KDIGO), all advocate treatment of anaemia in people with CKD. Blood transfusions are infrequently required, and newer therapies such as Hypoxia-Inducible Factor (HIF-PHI) stabilisers are now in current use. This guideline provides evidence based graded practice guidance on the use of iron; comments on iron deficiency without anaemia in people with CKD; provide further information on anaemia management in people with a transplant and provide guidance in the use of the new HIF-PHI drugs. It also provides audit and research recommendations. |
| format | Article |
| id | doaj-art-ce01baa1e63542a4aade5e6bbcce36b9 |
| institution | OA Journals |
| issn | 1471-2369 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Nephrology |
| spelling | doaj-art-ce01baa1e63542a4aade5e6bbcce36b92025-08-20T02:24:26ZengBMCBMC Nephrology1471-23692025-04-0126113710.1186/s12882-025-04115-1UK kidney association clinical practice guideline: update of anaemia of chronic kidney diseaseSunil Bhandari0Sebastian Spencer1Ben Oliveira2Ashraf Mikhail3Owain Brooks4Gareth Bryant5Michelle Willicombe6Richard Baines7Louise Alldridge8Sally Haslam-England9Hull University Teaching Hospitals NHS TrustHull University Teaching Hospitals NHS TrustBarts Health NHS TrustSwansea Bay University Health BoardSwansea Bay University Health BoardCardiff and Vale University Health BoardImperial College Health Care TrustUniversity Hospitals of Leicester NHS TrustNew Cross HospitalNottingham University Hospitals NHS TrustAbstract Anaemia is common in chronic kidney disease (CKD) encompassing non-dialysis dependent CKD (NDD-CKD) and dialysis dependent CKD (DD-CKD); people on peritoneal dialysis (PD) and haemodialysis (HD); and kidney transplant recipients (KTR). Iron deficiency and erythropoietin deficiency are the most common causes of anaemia in people with CKD, especially those requiring kidney replacement therapy (KRT). The Renal National Service Framework and National Institute for Health and Clinical Excellence in the UK, and Kidney Disease Improving Global Outcomes (KDIGO), all advocate treatment of anaemia in people with CKD. Blood transfusions are infrequently required, and newer therapies such as Hypoxia-Inducible Factor (HIF-PHI) stabilisers are now in current use. This guideline provides evidence based graded practice guidance on the use of iron; comments on iron deficiency without anaemia in people with CKD; provide further information on anaemia management in people with a transplant and provide guidance in the use of the new HIF-PHI drugs. It also provides audit and research recommendations.https://doi.org/10.1186/s12882-025-04115-1AnaemiaErythropoietin, Hypoxia inducible factor prolyl hydroxylaseIronKidneyTransplant |
| spellingShingle | Sunil Bhandari Sebastian Spencer Ben Oliveira Ashraf Mikhail Owain Brooks Gareth Bryant Michelle Willicombe Richard Baines Louise Alldridge Sally Haslam-England UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease BMC Nephrology Anaemia Erythropoietin, Hypoxia inducible factor prolyl hydroxylase Iron Kidney Transplant |
| title | UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease |
| title_full | UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease |
| title_fullStr | UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease |
| title_full_unstemmed | UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease |
| title_short | UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease |
| title_sort | uk kidney association clinical practice guideline update of anaemia of chronic kidney disease |
| topic | Anaemia Erythropoietin, Hypoxia inducible factor prolyl hydroxylase Iron Kidney Transplant |
| url | https://doi.org/10.1186/s12882-025-04115-1 |
| work_keys_str_mv | AT sunilbhandari ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT sebastianspencer ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT benoliveira ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT ashrafmikhail ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT owainbrooks ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT garethbryant ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT michellewillicombe ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT richardbaines ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT louisealldridge ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease AT sallyhaslamengland ukkidneyassociationclinicalpracticeguidelineupdateofanaemiaofchronickidneydisease |